Research Project 1
研究项目1
基本信息
- 批准号:10738712
- 负责人:
- 金额:$ 39.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-20 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAdultAgeBreast Cancer DetectionCancer ControlCancer EtiologyCaringCellular PhoneCervical Cancer ScreeningColonoscopyColorectal CancerCountryDevelopmentDiagnosticDissemination and ImplementationEarly DiagnosisEffectivenessElectronic Health RecordEvidence based interventionFamilyFeedbackFundingGastroenterologistGoalsHealth PersonnelHealth systemHealthcareHealthcare SystemsHybridsIncidenceInstitutionIntegrated Health Care SystemsInterruptionInterventionInterviewKnowledgeLinkLocal GovernmentMalignant NeoplasmsMapsMeasuresMedical Care TeamMethodsMexicanMexicoModelingMorbidity - disease ratePatient EducationPatientsPopulationProcessPublic HealthRecordsResearchResearch Project GrantsResource-limited settingResourcesRiskScientific Advances and AccomplishmentsScreening for cancerSeriesSpecialistStandardizationTelephoneTestingTexasText MessagingTimeTrainingWomanarmcolorectal cancer screeningcostcost effectivecost effectivenessdesigneconomic costeconomic evaluationeffectiveness evaluationeffectiveness outcomeeffectiveness/implementation studyevidence baseimplementation designimplementation facilitatorsimplementation outcomesimplementation researchimplementation scienceimplementation strategyimprovedincremental costmembermenmicrocostingmortalityorganizational readinesspatient navigationpatient screeningprimary care clinicianprogramsprospectiverelative costresearch studyretireescreeningscreening guidelinesscreening programtesting uptakevirtual
项目摘要
PROJECT SUMMARY
Colorectal cancer (CRC) is exerting a significant public health impact in Mexico despite the availability of
effective screening strategies. Yet, there are no national CRC screening (CRCS) guidelines or organized CRCS
programs in Mexico. We aim to implement a CRCS program in an integrated health system that is context-
appropriate, sustainable, scalable, and easily transferable to different health systems in Mexico. We will
optimize FIT uptake and CRCS completion by adapting and evaluating evidence-based interventions (EBIs)
(patient education, patient reminders, patient navigation); designing implementation strategies (training with
technical assistance, practice champions, audit and feedback) to deliver these EBIs; and evaluating the
effectiveness, cost-effectiveness, and implementation outcomes using a type 2 hybrid effectiveness
implementation study. Our proposed research is potentially groundbreaking and of substantial public health
significance in that it will be the first implementation research study in Mexico to address CRCS while applying
rigorous implementation science methods. It will advance scientific knowledge on the effectiveness of EBIs that
have been developed and tested in other countries and adapted for use in Mexico; it will also study the impact
of implementation strategies to deliver them in a real-world setting. Our proposed study will incorporate an
economic evaluation of the implementation of the EBIs to provide healthcare institutions with the necessary
information to plan for adoption and sustainability in settings with different resources.
项目摘要
结肠直肠癌(CRC)正在墨西哥产生重大的公共卫生影响,尽管有
有效的筛选策略。然而,没有国家CRC筛查(CRCS)指南或有组织的CRCS
墨西哥的节目。我们的目标是在一个综合卫生系统中实施CRCS计划,
适当的,可持续的,可扩展的,易于转移到墨西哥的不同卫生系统。我们将
通过调整和评估循证干预措施(EBI),优化FIT的采用和CRCS的完成
(患者教育、患者提醒、患者导航);设计实施策略(培训
技术援助、实践倡导者、审计和反馈),以交付这些EBI;
使用第2类混合有效性的有效性、成本有效性和实施结果
执行研究。我们提议的研究具有潜在的开创性和重大的公共卫生意义
重要性在于,这将是墨西哥第一次实施研究,以解决CRCS,同时应用
严格执行科学方法。它将推进关于EBI有效性的科学知识,
已经在其他国家开发和测试,并在墨西哥使用;它还将研究
实施战略,以在现实世界中实现这些目标。我们建议的研究将包括
经济评估的实施EBI提供医疗机构必要的
信息,以便在拥有不同资源的环境中规划采用和可持续性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Lajous其他文献
Martin Lajous的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Lajous', 18)}}的其他基金
Aflatoxin exposure and hepatocellular carcinoma in Mexico
墨西哥的黄曲霉毒素暴露与肝细胞癌
- 批准号:
10238151 - 财政年份:2020
- 资助金额:
$ 39.96万 - 项目类别:
Aflatoxin exposure and hepatocellular carcinoma in Mexico
墨西哥的黄曲霉毒素暴露与肝细胞癌
- 批准号:
10614766 - 财政年份:2020
- 资助金额:
$ 39.96万 - 项目类别:
Mesoamerican Center for Population Health Research on Non-Communicable Disease
中美洲非传染性疾病人口健康研究中心
- 批准号:
9335326 - 财政年份:2016
- 资助金额:
$ 39.96万 - 项目类别:
Coordinating Unit of the Mesoamerican Center for Population Health Research on Non-Communicable Disease
中美洲非传染性疾病人口健康研究中心协调单位
- 批准号:
9193994 - 财政年份:
- 资助金额:
$ 39.96万 - 项目类别:
Coordinating Unit of the Mesoamerican Center for Population Health Research on Non-Communicable Disease
中美洲非传染性疾病人口健康研究中心协调单位
- 批准号:
9335327 - 财政年份:
- 资助金额:
$ 39.96万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Standard Grant